Back to Agenda
Investigational Medicinal Products: eLabeling Initiative, Supply Forecasting Strategies, and Patient-Centric Technology for Medicine Adherence
Session Chair(s)
Mark Paul, MBA
Customer Success Manager
Medable Inc., United States
This session will discuss three key aspects in digitally supporting Investigational Medicinal Product (IMP) management and adherence. The topics include a cross-industry patient-centric eLabeling initiative, next generation clinical supply forecasting, and a case study of patient centric technology supporting medication adherence.
Learning Objective : Discuss concepts of eLabeling and digitally supported, patient-centric clinical supply chains; Describe the clinical forecasting landscape and evaluate the role of technology to support supply strategies; Describe a case study of patient-centric technology supporting medical adherence.
Speaker(s)
Leveraging Real World Evidence and Patient-Centric Technology to Drive a Virtual Study of Treatment Adherence: A Case Study
Mark Paul, MBA
Medable Inc., United States
Customer Success Manager
Evolving Clinical Supply Forecasting Strategies to Drive Supply Chain Efficiency
Jan Pieter Kappelle, MS
4G Clinical, Belgium
Vice President, Strategy
eLabels: A Cross-Industry Perspective on Managing IMP with Patient-Centric Technology
Jennie Deem, BSN, RN
Eli Lilly and Company, United States
Regulatory Consultant, Clinical Trial Labeling and Supplies
Have an account?